UBS O'Connor’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-238,623
Closed -$2.42M 749
2022
Q3
$2.42M Sell
238,623
-23,888
-9% -$241K 0.03% 507
2022
Q2
$2.64M Buy
+262,511
New +$2.63M 0.03% 500
2022
Q1
Sell
-257,885
Closed -$2.57M 605
2021
Q4
$2.57M Buy
+257,885
New +$2.55M 0.02% 446

Other funds holding THAC

UBS O'Connor's THAC Position: Q4 2022 in Review

UBS O'Connor sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.42M sold.

UBS O'Connor first reported a position in THAC in Q4 2021 and held it in 3 quarters. The position peaked at $2.64M in Q2 2022. 48 funds tracked by Wall St. Rank hold THAC as of Q4 2022.

  • UBS O'Connor reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 238,623 Thrive Acquisition Corporation Class A ordinary shares shares in Q4 2022, an estimated $2.42M.
  • UBS O'Connor first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2021 and held it in 3 quarters.
  • UBS O'Connor's Thrive Acquisition Corporation Class A ordinary shares position peaked at $2.64M in Q2 2022.
  • 48 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.